3/20/2012

Data on 566 patients with traumatic brain injuries revealed those who received erythropoiesis-stimulating agents were 75% less likely to die of the condition compared with those not given the red blood cell-producing agents. The findings appear in the journal Archives of Surgery.

Related Summaries